ORIGINAL RESEARCH—BASIC SCIENCE: Effects of ACE Inhibition and Beta-Blockade on Female Genital Structures in Spontaneously Hypertensive Rats
Corresponding Author
Jorge E. Toblli MD, PhD
Laboratory of Experimental Medicine, Hospital Alemán, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina;
Jorge E. Toblli, MD, PhD, Laboratory of Experimental Medicine, Hospital Alemán, Av. Pueyrredon 1640, Buenos Aires 1118, Argentina. Tel: 54-11-4827-7000; Fax: 54-11-4805-6087; E-mail: [email protected]Search for more papers by this authorGabriel Cao MD
Laboratory of Experimental Medicine, Hospital Alemán, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina;
Search for more papers by this authorAdolfo R. Casabé MD
Sexual Dysfunction Section, Urology Division, Hospital Durand, Buenos Aires, Argentina
Search for more papers by this authorAmado J. Bechara MD
Sexual Dysfunction Section, Urology Division, Hospital Durand, Buenos Aires, Argentina
Search for more papers by this authorCorresponding Author
Jorge E. Toblli MD, PhD
Laboratory of Experimental Medicine, Hospital Alemán, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina;
Jorge E. Toblli, MD, PhD, Laboratory of Experimental Medicine, Hospital Alemán, Av. Pueyrredon 1640, Buenos Aires 1118, Argentina. Tel: 54-11-4827-7000; Fax: 54-11-4805-6087; E-mail: [email protected]Search for more papers by this authorGabriel Cao MD
Laboratory of Experimental Medicine, Hospital Alemán, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina;
Search for more papers by this authorAdolfo R. Casabé MD
Sexual Dysfunction Section, Urology Division, Hospital Durand, Buenos Aires, Argentina
Search for more papers by this authorAmado J. Bechara MD
Sexual Dysfunction Section, Urology Division, Hospital Durand, Buenos Aires, Argentina
Search for more papers by this authorABSTRACT
Introduction and Aim. This study evaluated the possible differences between an angiotensin converting enzyme (ACE) inhibitor and a beta-blocker concerning their potential protective role on female external genitalia in spontaneously hypertensive rats (SHR).
Main Outcome Measures. Morphological changes in the clitoris after antihypertensive treatments.
Methods. For 6 months, SHR received no treatment; SHR + ramipril (RAM), SHR + atenolol (AT), and control Wistar Kyoto (WKY) rats received no treatment. Clitorises were processed for immunohistochemistry using anti-α-smooth muscle actin (α-SMA), anti-collagen I and III, anti-transforming growth factor β1 (TGFβ1), and anti-endothelial nitric oxide synthase (eNOS) antibodies.
Results. SHR + RAM and SHR + AT presented significantly lower blood pressure in both groups vs. untreated SHR. Compared with WKY, α-SMA was increased in the arteries and in the cavernous spaces of the clitoris together with a marked increase in wall/lumen ratio in clitoral vessels in untreated SHR. All these alterations were diminished in SHR + AT (P < 0.01). SHR + RAM presented differences with respect to SHR + AT in the reduction of these variables. TGFβ1 expression in the vessel wall from the clitoris and collagen I and III deposition in the interstitium from the clitoris in untreated SHR were significantly more (P < 0.01) than in WKY. While SHR + AT showed a mild decrease in these variables, SHR + RAM presented a significant reduction (P < 0.01) in TGFβ1 expression interstitial fibrosis and in both types of collagens. Positive immunostaining of eNOS in the sinusoidal endothelium from the clitoris was less (P < 0.01) in untreated SHR (3.4 ± 1.3%) and SHR + AT (5.1 ± 1.2%) than in SHR + RAM (17.2 ± 1.6%) and WKY (15.9 ± 1.7%). Untreated SHR and SHR + AT presented more surrounding connective tissue at the perineurium in the clitoris (P < 0.01) than SHR + RAM.
Conclusion. ACE inhibition provided a considerable protective role on the female external genitalia structures in SHR by a mechanism that may be, at least in part, independent of the degree of blood pressure lowering. Toblli JE, Cao G, Casabé AR, and Bechara AJ. Effects of ACE inhibition and beta-blockade on female genital structures in spontaneously hypertensive rats. J Sex Med 2007;4:1593–1603.
References
- 1 Hatzimouratidis K, Hatzichristou D. Sexual dysfunctions: Classifications and definitions. J Sex Med 2007; 4: 241–50.
- 2 Goldstein I. Current management strategies of the postmenopausal patient with sexual health problems. J Sex Med 2007; 4(3 suppl): 235–53.
- 3 Burchardt M, Burchardt T, Anastasiadis AG, Kiss AJ, Baer L, Pawar RV, De La Taille A, Shabsigh A, Ghafar MA, Shabsigh R. Sexual dysfunction is common and overlooked in female patients with hypertension. J Sex Marital Ther 2003; 29: 247–8.
- 4 Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206–52.
- 5 Doumas M, Tsiodras S, Tsakiris A, Douma S, Chounta A, Papadopoulos A, Kanellakopoulou K, Giamarellou H. Female sexual dysfunction in essential hypertension: A common problem being uncovered. J Hypertens 2006; 24: 2387–92.
- 6 Grimm RH Jr, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, Yunis C, Svendsen K, Liebson PR, Elmer PJ. Long term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women: Treatment of Mild Hypertension Study (TOMHS). Hypertension 1997; 29: 8–14.
- 7 Duncan LE, Lewis C, Jenkins P, Pearson TA. Does hypertension and its pharmacotherapy affect the quality of sexual function in women? Am J Hypertens 2000; 13: 640–7.
- 8 Lewis RW, Fugl-Meyer KS, Bosch R, Fugl-Meyer AR, Laumann EO, Lizza E, Martin-Morales A. Epidemiology/risk factors of sexual dysfunction. J Sex Med 2004; 1: 35–9.
- 9 Hale TM, Heaton JPW, Adams MA. A framework for the present and future development of experimental models of female sexual dysfunction. Int J Impot Res 2003; 15(5 suppl): S75–9.
- 10 Min K, O'Connell L, Munarriz R, Huang YH, Choi S, Kim N, Goldstein I, Traish A. Experimental models for the investigation of female sexual function and dysfunction. Int J Impot Res 2001; 13: 151–6.
- 11 Park K, Goldstein I, Andry C, Siroky MB, Krane RJ, Azadzoi KM. Vasculogenic female sexual dysfunction: the hemodynamic basis for vaginal engorgement insufficiency and clitoris erectile insufficiency. Int J Impot Res 1997; 9: 27–37.
- 12 Duncan LE, Lewis C, Smith CE, Jenkins P, Nichols M, Pearson TA. Sex, drugs, and hypertension: A methodological approach for studying a sensitive subject. Int J Impot Res 2001; 13: 31–40.
- 13 Bechara AJ, Cao G, Casabé AR, Romano SV, Toblli JE. Morphological modifications in clitoris and vagina in spontaneously hypertensive rats. Int J Impot Res 2003; 15: 166–72.
- 14 Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) immunoperoxidase techniques: A comparison between ABC an unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577–80.
- 15 Giuliano F, Allard J. The experimental physiology of the genital female response. Int J Impot Res 2001; 13(4 suppl): S4 [Abstract.
- 16 Goldstein I, Berman JR. Vasculogenic female sexual dysfunction: Vaginal engorgement and clitoral erectile insufficiency syndromes. Int J Impot Res 1998; 10: S84–90.
- 17 Mazza ON, Angerosa M, Becher E, Toblli JE. Differences between Candesartan and Hydralazine in the protection of penile structures in spontaneously hypertensive rats. J Sex Med 2006; 3: 604–11.
- 18 Derhaschnig U, Shehata M, Herkner H, Bur A, Woisetschlager C, Laggner AN, Hirschl MM. Increased levels of transforming growth factor-beta1 in essential hypertension. Am J Hypertens 2002; 15: 207–11.
- 19 Xu C, Lee S, Singh TM, Sho E, Li X, Sho M, Masuda H, Zarins CK. Molecular mechanisms of aortic wall remodeling in response to hypertension. J Vasc Surg 2001; 33: 570–8.
- 20 Joki N, Kaname S, Hirakata M, Hori Y, Yamaguchi T, Fujita T, Katoh T, Kurokawa K. Tyrosine-kinase dependent TGF-beta and extracellular matrix expression by mechanical stretch in vascular smooth muscle cells. Hypertens Res 2000; 23: 91–9.
- 21 Siegert A, Ritz E, Orth S, Wagner J. Differential regulation of transforming growth factor receptors by angiotensin II and transforming growth factor-beta1 in vascular smooth muscle. J Mol Med 1999; 77: 437–45.
- 22 O’Callaghan CJ, Williams B. The regulation of human vascular smooth muscle extracellular matrix protein production by alpha- and beta-adrenoceptor stimulation. J Hypertens 2002; 20: 287–94.
- 23 Brilla CG. Regression of myocardial fibrosis in hypertensive heart disease: Diverse effects of various antihypertensive drugs. Cardiovasc Res 2000; 46: 324–31.
- 24 Schiffrin EL. Effect of antihypertensive treatment on small artery remodeling in hypertension. Can J Physiol Pharmacol 2003; 81: 168–76.
- 25 Toblli JE, Stella I, Mazza ON, Ferder L, Inserra F. Protection of cavernous tissue in male spontaneously hypertensive rats. Beyond blood pressure control. Am J Hypertens 2004; 17: 516–22.
- 26 Toblli JE, Stella I, De Cavanagh EMV, Angerosa M, Inserra F, Ferder L. Enalapril prevents tubulointerstitial lesions by hyperoxaluria. Hypertension 1999; 33: 225–31.
- 27 De Cavanagh EMV, Inserra F, Toblli JE, Stella I, Fraga C, Ferder L. Enalapril attenuates oxidative stress in diabetic rats. Hypertension 2001; 38: 1130–6.
- 28 Toblli JE, Ferder L, Stella I, Angerosa M, Inserra F. Enalapril prevents fatty liver in nephrotic rats. J Nephrol 2002; 15: 358–67.
- 29 Toblli JE, DeRosa G, Cao G, Piorno P, Pagano P. ACE inhibitor and angiotensin type I receptor antagonist in combination reduce renal damage in obese Zucker rats. Kidney Int 2004; 65: 2343–59.
- 30 Toblli JE, Cao G, DeRosa G, Forcada P. Reduced cardiac expression of plasminogen activator inhibitor 1 and transforming growth factor beta1 in obese Zucker rats by perindopril. Heart 2005; 91: 80–6.
- 31 Zvara P, Sioufi R, Schipper HM, Begin LR, Brock GB. Nitric oxide mediated erectile activity is a testosterone dependent event: A rat erection model. Int J Impot Res 1995; 7: 209–19.
- 32 Goldstein I. Female sexual arousal disorders new insights. Int J Impot Res 2000; 12(4 suppl): S152–7.
- 33 Burnett AL, Calvin DC, Silver RI, Peppas DS, Docimo SG. Immunohistochemical description of nitric oxide synthase isoforms in human clitoris. J Urol 1997; 158: 75–8.
- 34 Berman J, McCarthy M, Kyprianou N. Effect of estrogen withdrawal on nitric oxide synthase expression and apoptosis in the rat vagina. Urology 1998; 51: 650–98.
- 35 Ushiyama M, Morita T, Kuramochi T, Yagi S, Katayama S. Erectile dysfunction in hypertensive rats results from impairment of the relaxation evoked by neurogenic carbon monoxide and nitric oxide. Hypertens Res 2004; 27: 253–61.
- 36 Behr-Roussel D, Chamiot-Clerc P, Bernabe J, Mevel K, Alexandre L, Safar ME, Giuliano F. Erectile dysfunction in spontaneously hypertensive rats: Pathophysiological mechanisms. Am J Physiol Regul Integr Comp Physiol 2003; 284: R682–8.
- 37 Behr-Roussel D, Gorny D, Mevel K, Compagnie S, Kern P, Sivan V, Bernabe J, Bedigian MP, Alexandre L, Giuliano F. Erectile dysfunction: An early marker for hypertension? A longitudinal study in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2005; 288: R276–83.
- 38 Stier CT Jr, Chander PN, Rosenfeld L, Powers CA. Estrogen promotes microvascular pathology in female stroke-prone spontaneously hypertensive rats. Am J Physiol Endocrinol Metab 2003; 285: E232–9.
- 39 Hamilton CA, Groves S, Carswell HV, Brosnan MJ, Graham D, Dominiczak AF. Estrogen treatment enhances nitric oxide bioavailability in normotensive but not hypertensive rats. Am J Hypertens 2006; 19: 859–66.
- 40 Pinto S, Virdis A, Ghiadoni L, Bernini G, Lombardo M, Petraglia F, Genazzani AR, Taddei S, Salvetti A. Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women. Hypertension 1997; 29: 268–73.
- 41 Monsalve E, Oviedo PJ, García-Pérez MA, Tarín JJ, Cano A, Hermenegildo C. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells. Cardiovasc Res 2007; 73: 66–72.
- 42 Huang A, Sun D, Koller A, Kaley G. 17β-estradiol Restores endothelial nitric oxide release to shear stress in arterioles of male hypertensive rats. Circulation 2000; 101: 94–100.
- 43 Mori T, Durand J, Chen Y, Thompson A, Bakir S, Oparil S. Effects of short-term estrogen treatment on the neointimal response to balloon injury of rat carotid artery. Am J Cardiol 2000; 85: 1276–9.
- 44 Gimenez J, Garcia MP, Serna M, Bonacasa B, Carbonell LF, Quesada T, Hernandez I. 17β-oestradiol enhances the acute hypotensive effect of captopril in female ovariectomized spontaneously hypertensive rats. Exp Physiol 2006; 91: 715–22.
- 45 Dorrance AM, Lewis RW, Mills TM. Captopril treatment reverses erectile dysfunction in stroke prone spontaneously hypertensive rats. Int J Impot Res 2002; 14: 494–7.
- 46 Hale TM, Okabe H, Heaton JPW, Adams MA. Antihypertensive drugs induce structural remodeling of the penile vasculature. J Urol 2001; 166: 739–45.
